Burleson Research Technologies is a contract research organization headquartered outside of Raleigh, North Carolina. We specialize in providing laboratory services to biotechnology, pharmaceutical, chemical manufacturing, government, and healthcare industries, with a specific focus on preclinical immunotoxicology studies. Our mission is to deliver quality science and client-centric solutions that assess immune safety and improve human and animal health. With a comprehensive range of services, from immune function evaluations to infectious disease models and cytokine and complement assays, we offer an array of in vivo and in vitro preclinical research services. Our dedicated team is committed to providing reliable and accurate data to clients who seek to test the efficacy and immunotoxicity of their pharmaceuticals, biologics, or chemicals. At BRT Labs, we strive to exceed expectations and contribute to advancements in scientific research and development.